Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
48 Inflation Busters Feature 8 Ideal Dividend Dogs
05:16am, Thursday, 28'th Apr 2022 Seeking Alpha
March-April 2022, UBS, Kiplinger, and Barron's analysts/reporters combined to list 5 sets of stocks sorted as inflation busters for 2022, featuring 8 dividend dogs.
Innoviva (INVA) Surpasses Q1 Earnings and Revenue Estimates
10:45pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Innoviva (INVA) delivered earnings and revenue surprises of 5% and 76.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What is Paxlovid, Pfizer’s COVID antiviral drug, and how effective is it?
04:55pm, Wednesday, 27'th Apr 2022 MarketWatch
What to know about Paxlovid, its availability, side effects and more. The pill can decrease hospitalization or death from COVID-19 in high-risk adults by 89%.
Glaxo's (GSK) Q1 Earnings Top, Xevudy Adds $1.7B in Sales
03:10pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Glaxo's (GSK) revenues benefit from the strong growth in sales across all categories along with additional sales from its COVID-19 antibody drug, Xevudy.
Many Americans feel the pandemic is over, but new, highly transmissible and immune-evasive variants are likely, says White House COVID response coordinator
11:57am, Wednesday, 27'th Apr 2022 MarketWatch
The U.S. is in a 'complicated' moment in the pandemic where cases are relatively low and hospitalizations close to the lowest levels since the start of the crisis, making many feel that it's all over.
3 Things to Know About Amazon Ahead of Its Stock Split
10:30am, Wednesday, 27'th Apr 2022 The Motley Fool
Are share gains on the way?
Should You Invest in the Vanguard Health Care ETF (VHT)?
10:20am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Sector ETF report for VHT
Does This News From Novavax Mean Trouble for Moderna?
10:00am, Wednesday, 27'th Apr 2022 The Motley Fool
It could put Novavax a step ahead in a post-pandemic world.
Pfizer (PFE) Gains As Market Dips: What You Should Know
09:45pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
In the latest trading session, Pfizer (PFE) closed at $49.03, marking a +0.16% move from the previous day.
Why Pfizer Stock Rose Today While the Market Tanked
09:16pm, Tuesday, 26'th Apr 2022 The Motley Fool
The company and its partner Valneva had some good news to report.
Pfizer (PFE) Reports Next Week: Wall Street Expects Earnings Growth
07:01pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Healthcare ETFs in Focus Ahead of Q1 Earnings
03:15pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo
White House makes push for access to COVID antiviral, urges Congress to fund next leg of pandemic response
01:56pm, Tuesday, 26'th Apr 2022 MarketWatch
President Joe Biden's administration is pushing to expand availability of COVID-19 antiviral treatment Paxlovid and is moving to raise awareness of the pill and taking steps to make it easier to acce
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Protagonist's Ulcerative Colitis Study Disappoints With Higher Dose Of PN-943
Protagonist Therapeutics
Did Johnson & Johnson's CFO Just Spell Trouble for Moderna and Pfizer?
12:10pm, Tuesday, 26'th Apr 2022 The Motley Fool
Demand for doses of the coronavirus vaccine isn't as reliably high as it once was.
